XOMA Corporation/ US98419J2069 /
2024-03-28 9:00:00 PM | Chg. +0.7100 | Volume | Bid9:00:10 PM | Ask9:00:10 PM | High | Low |
---|---|---|---|---|---|---|
24.0500USD | +3.04% | 19,834 Turnover: 306,681.7900 |
15.7600Bid Size: 500 | 26.0000Ask Size: 100 | 24.5400 | 23.2500 |
GlobeNewswire
03-25
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
03-25
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Director...
GlobeNewswire
03-19
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender...
GlobeNewswire
03-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
03-18
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – TGAN, HMST, KNTE
GlobeNewswire
03-13
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – KNTE, DOOR, HMST
GlobeNewswire
03-13
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Whole Earth...
GlobeNewswire
03-08
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming ...
GlobeNewswire
03-07
Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busine...
GlobeNewswire
03-07
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – BATL, MDC,...
GlobeNewswire
03-01
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of...
GlobeNewswire
03-01
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Labo...
GlobeNewswire
02-26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AVROBIO, In...
GlobeNewswire
02-23
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger – KAMN, ERF,...